Tennessee Oncology-Chattanooga /Sarah Cannon Research Institute/SCRI — Chattanooga, Tennessee

Tennessee Oncology-Chattanooga /Sarah Cannon Research Institute/SCRI is a clinical research site located in Chattanooga, Tennessee, United States 37404.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Tennessee Oncology-Chattanooga /Sarah Cannon Research Institute/SCRI has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Breast Neoplasm, Neoplasm Metastasis.

Sponsors: Eli Lilly and Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chattanooga

Browse all research sites in Tennessee · View every site in Chattanooga

• University of Tennessee/Erlanger Oncology and Hematology
• University of Tennessee Erlanger Cardiology
• University Oncology/ Hematology Associates
• Center for Sports Medicine and Orthopaedics; Memorial Hospital
• Children's Hospital at Erlanger
• University of Tennessee-Chattanooga Unit
• University Oncology and Hematology Associates
• Memorial Hospital
• University of Diabetes and Endocrine Consultants
• University Diabetes & Endocrine Consultants /ID# 170392
• University of Tennessee Erlanger Oncology & Hematology
• Parkridge East Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology-Chattanooga /Sarah Cannon Research Institute/SCRI?

Tennessee Oncology-Chattanooga /Sarah Cannon Research Institute/SCRI has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology-Chattanooga /Sarah Cannon Research Institute/SCRI conducted?

Tennessee Oncology-Chattanooga /Sarah Cannon Research Institute/SCRI has 1 clinical trials on record, with 1 currently active. Their work covers Breast Neoplasm, Neoplasm Metastasis.

Is Tennessee Oncology-Chattanooga /Sarah Cannon Research Institute/SCRI accredited by Crixeo Clinical Trials?

Tennessee Oncology-Chattanooga /Sarah Cannon Research Institute/SCRI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology-Chattanooga /Sarah Cannon Research Institute/SCRI?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.